Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4126-4132

  Zhang, Hong ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ANTIBODY SPECIFICITY; ARTICLE; CANCER SURVIVAL; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033398992     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Starzynska, T., Bromley, M., Ghosh, A., and Stern, P. L. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br. J. Cancer, 66: 558-562, 1992.
3. Auvinen, A., Isola, J., Visakorpi, T., Koivula, T., Virtanen, S., and Hakama, M. Overexpression of p53 and long-term survival in colon carcinoma. Br. J. Cancer, 70: 293-296, 1994.
4. Bosari, S., Viale, G., Bossi, P., Maggioni, M., Coggi, G., Murray, J. J., and Lee, A. K. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J. Natl. Cancer Inst., 86: 681-687, 1994.
5. Diez, M., Enriquez, J. M., Camunas, J., Gonzalez, A., Gutierrez, A., Muguerza, J. M., Ruiz, A., and Granell, J. Prediction of recurrence in B-C stages of colorectal cancer by p53 nuclear overexpression in comparison with standard pathological features. Eur. J. Surg. Oncol., 21: 635-639, 1995.
6. Tomoda, H., and Kakeji, Y. Immunohistochemical analysis of p53 in colorectal cancer regarding clinicopathological correlation and prognostic significance. J. Surg. Oncol., 58: 125-128, 1995.
7. Flamini, G., Curigliano, G., Ratto, C., Astone, A., Ferretti, G., Nucera. P., Sofo, L., Sgambato, A., Boninsegna, A., Crucitti, F., and Cittadini, A. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer: an immunohistochemical analysis. Eur. J. Cancer, 32: 802-806, 1996.
8. Langlois, N. E., Lamb, J., Eremin, O., and Heys, S. D. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J. Pathol., 182: 392-397, 1997.
9. Starzynska, T., Bromley, M., Marlicz, K., Roberts, S. A., Ucinski, M., and Stern, P. L. Accumulation of p53 in relation to long-term prognosis in colorectal carcinoma. Eur. J. Gastroenterol. Hepatol., 9: 183-186, 1997.
10. Purdie, C. A., O'Grady, J., Piris, J., Wyllie, A. H., and Bird, C. C. p53 expression in colorectal tumors. Am. J. Pathol., 138: 807-813, 1991.
11. Yamaguchi, A., Kurosaka, Y., Fushida, S., Kanno, M., Yonemura, Y., Miwa, K., and Miyazaki, I. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer (Phila.), 70: 2778-2784, 1992.
12. Yamaguchi., A., Nakagawara, G., Kurosaka, Y., Nishimura, G., Yonemura, Y., and Miyazaki, I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br. J. Cancer, 68: 399-402, 1993.
13. Darmon, E., Cleary, K. R., and Wargovich, M. J. Immunohistochemical analysis of p53 overexpression in human colonie tumors. Cancer Detect. Prev., 18: 187-195, 1994.
14. Nathanson, S. D., Linden, M. D., Tender, P., Zarbo, R. J., Jacobsen, G., and Nelson, L. T. Relationship among p53, stage, and prognosis of large bowel cancer. Dis. Colon Rectum, 37: 527-534, 1994.
15. Suzuki, H., Matsumoto, K., Koide, A., Tada, T., Fujino, I., Okuda, A., and Shigemori, C. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma. Surg. Today, 24: 85-87, 1994.
16. Zeng, Z. S., Sarkis, A. S., Zhang, Z. F., Klimstra, D. S., Charytonowicz, E., Guillem, J. G., Cordon-Cardo, C., and Cohen, A. M. p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J. Clin. Oncol., 12: 2043-2050, 1994.
17. Grewal, H., Guillem, J. G., Klimstra, D. S., and Cohen, A. M. p53 nuclear overexpression may not be an independent prognostic marker in early colorectal cancer. Dis. Colon Rectum, 38: 1176-1181, 1995.
18. Lazaris, A. C., Theodoropoulos, G. E., Anastassopoulos, P., Nakopoulou, L., Panoussopoulos, D., and Papadimitriou, K. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma. Histol. Histopathol., 10: 661-668, 1995.
19. Belluco, C., Guillem, J. G., Kerneny, N., Huang, Y., Klimstra, D., Berger, M. F., and Cohen, A. M. p53 nuclear protein overexpression in colorectal cancer: a dominantpredictor of survival in patients with advanced hepatic metastases. J. Clin. Oncol., 14: 2696-2701, 1996.
20. Fante, R., Di Gregorio, C., Losi, L., Roncucci, L., and Ponz, de Leon, M. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer: Colorectal Cancer Study Group of the University and Health Care District of Modena. Ital. J. Gastroenterol., 28: 205-210, 1996.
21. Paradiso, A., Rabinovich, M., Vallejo, C., Machiavelli, M., Romero, A., Perez, J., Lacava, J., Cuevas, M. A., Rodriquez, R., Leone, B., Sapia, M. G., Simone, G., and De Lena, M. p53, and PCNA expression in advanced colorectal cancer: response to chemotherapy and long-term prognosis. Int. J. Cancer, 69: 437-441, 1996.
22. Smith, D. R., Ji, C. Y., and Goh, H. S. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br. J. Cancer. 74: 216-223, 1996.
23. Dix, B. R., Robbins, P., Soong, R., Jenner, D., House, A. K., and Iacopetta, B. J. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int. J. Cancer, 59: 747-751, 1994.
24. Kim, Y. W., Lee, S., Park, J. H., Yoon, T. Y., Park, Y. K., and Yang, M. H. An immunohistochemical study of the expression of p53 protein in colon cancer. J. Korean Med. Sci., 10: 176-182, 1995.
25. Mulder, J. W., Baas, I. O., Polak, M. M., Goodman, S. N., and Offerhaus, G. J. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br. J. Cancer, 71: 1257-1262, 1995.
26. Lanza, G., Jr., Maestri, I., Dubini, A., Gafa, R., Santini, A., Ferretti, S., and Cavazzini, L. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. Am. J. Clin. Pathol., 105: 604-612, 1996.
27. Leahy, D. T., Salman, R., Mulcahy, H., Sheahan, K., O'Donoghue, D. P., and Parfrey, N. A. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis. J. Pathol., 180: 364-370, 1996.
28. Pereira, H., Silva, S., Juliao, R., Garcia, P., and Perpetua, F. Prognostic markers for colorectal cancer: expression of P53 and BCL2. World J. Surg., 21: 210-213, 1997.
29. Soong, R., Grieu, F., Robbins, P., Dix, B., Chen, D., Parsons, R., House, A., and Iacopetta, B. p53 alterations are associated with improved prognosis in distal colonie carcinomas. Clin. Cancer Res., 3: 1405-1411, 1997.
30. Kaklamanis, L., Savage, A., Whitehouse, R., Doussis-Anagnostopoulou, I., Biddolph, S., Tsiotos, P., Mortensen, N., Gatter, K. C., and Harris, A. L. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Br. J. Cancer, 77: 1864-1869, 1998.
31. Kressner, U., Inganas, M., Byding, S., Blikstad, I., Pahlman, L., Glimelius, B., and Lindmark, G. Prognostic value of p53 genetic changes in colorectal cancer. J. Clin. Oncol., 17: 593-599, 1999.
32. Baretton, G. B., Vogt, M., Muller, C., Diebold, J., Schneiderbanger, K., Schmidt, M., and Lohrs, U. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II). Scand. J. Gastroenterol., 31: 481-489, 1996.
33. Brett, M. C., Pickard, M., Green, B., Howel-Evans, A., Smith, D., Kinsella, A., and Poston, G. p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer. Eur. J. Surg. Oncol., 22: 182-185, 1996.
34. Poller, D. N., Baxter, K. J., and Shepherd, N. A. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br. J. Cancer, 75: 87-93, 1997.
35. Morson, B. C. Colour atlas of gastrointestinal pathology. In: R. C. Curran (ed.), Oxford Colour Atlases of Pathology. Oxford, United Kingdom: Oxford University Press, 1988.
36. Hermanek, P. Colorectal carcinoma: histopathological diagnosis and staging. Baillières Clin. Gastroenterol., 3: 511-529, 1989.
37. Sun, X-F., Carstensen, J. M., Stål, O., Wingren, S., Hatschek, T., Zhang, H., and Nordenskjöld, B. Prognostic significance of DNA ploidy and S-phase fraction in colorectal adenocarcinoma. Diagn. Oncol., 3: 121-126, 1993.
38. Sun, X. F., Carstensen, J. M., Stal, O., Zhang, H., and Nordenskjold, B. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2, p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma. Int. J. Cancer, 69: 5-8, 1996.
39. Armitage, P., and Berry, G. Statistical Methods in Medical Research. Oxford, United Kingdom: Blackwell Scientific Publications, 1987.
40. Cox, D. R. Regression models and life tables. J. R. Statist. Soc. B, 34: 187-220, 1972.
41. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc., 53: 457-481, 1958.
42. Baas, I. O., Mulder, J-W. R., and Offerhaus, J. A. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
43. Klotzsche, O., Etzrodt, D., Hohenberg, H., Bohn, W., and Deppert, W. Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (vimentin) scaffold. Oncogene, 16: 3423-3434, 1998.
44. Shi, S-R., Key, E. M., and Kalra, L. K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741-748, 1991.
45. Kressner, U., Lindmark, G., Gerdin, B., Pahlman, L., and Glimelius, B. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res., 16: 951-957, 1996.
46. Caldes, T., Iniesta, P., Vega, F. J., de Juan, C., Lopez, J. A., Diaz-Rubio, E., Fernandez, C., Cerdan, J., Balibrea, J. L., and Benito, M. Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer. Oncology, 55: 249-257, 1998.
47. Nitti, D., Belluco, C., Montesco, M. C., Bertorelle, R., Da Pian, P. P., Fassina, A., Ninfo, V., Chieco-Bianchi, L., and Lise, M. Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival. Eur. J. Cancer, 34: 851-855, 1998.
48. Frebourg, T., and Friend, S. H. Cancer risks from germline p53 mutations. J. Clin. Invest., 90: 1637-1641, 1992.
49. Adell, G., Sun, X-F., Stål, O., Klintenberg, C., Sjödahl, R., and Norrdenskjöld, B. p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother. Oncol., 51: 169-174, 1999.